Literature DB >> 1502760

Tumor-associated tissue inflammatory reaction and eosinophilia in primary superficial bladder cancer.

J Flamm1.   

Abstract

In a retrospective study the data of 428 patients with primary superficial transitional cell carcinoma of the bladder were evaluated. The histologic slides were reviewed for presence of a tumor-associated tissue inflammatory reaction, especially tumor-associated eosinophilia. Tumor-associated cell infiltration was found in 23.1 percent and tumor-associated eosinophilia in 2.1 percent. Tumor-associated cell infiltration was associated with less recurrences (p = 0.01). Tumor progression rate was not significantly influenced by tumor-associated cell infiltration. Tumor-related death rate was lower in the group with tumor-associated cell infiltrate (p = 0.50). Using the Cox regression model carcinoma in situ of the tumor margin, tumor-associated cell infiltrate, and grade of differentiation appeared to be important factors in the prognosis for survival.

Entities:  

Mesh:

Year:  1992        PMID: 1502760     DOI: 10.1016/0090-4295(92)90524-z

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Eosinophilic cystitis simulating invasive bladder cancer: a real diagnostic challenge.

Authors:  Muwafak Salman; Abdulla A Al-Ansari; Raidh A Talib; El Fadil El Malik; Issam A Al-Bozaom; Ahmed A Shokeir
Journal:  Int Urol Nephrol       Date:  2006-11-18       Impact factor: 2.370

Review 2.  Myeloid Cells as Targets for Therapy in Solid Tumors.

Authors:  Tiziana Cotechini; Terry R Medler; Lisa M Coussens
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

3.  Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis.

Authors:  Guoming Hu; Shimin Wang; Kefang Zhong; Feng Xu; Liming Huang; Wei Chen; Pu Cheng
Journal:  BMC Cancer       Date:  2020-05-20       Impact factor: 4.430

4.  Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis.

Authors:  B V Offersen; M M Knap; N Marcussen; M R Horsman; S Hamilton-Dutoit; J Overgaard
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.